# Anshi Pharmaceutical (Zhongshan) Inc. – FDA Inspection, Oct 31, 2012

Source: https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/5ba36e06-8bcf-46e9-aef1-8c70336d0c9c
Source feed: FDA_Inspections

> FDA inspection 823594 of Anshi Pharmaceutical (Zhongshan) Inc., October 31, 2012. Classification: Voluntary Action Indicated (VAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 823594
- Company Name: Anshi Pharmaceutical (Zhongshan) Inc.
- Inspection Date: 2012-10-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1031944 - 2017-10-27](https://www.keypedia.com/records/fda_inspections/anshi-pharmaceutical-zhongshan-inc/3bc27a1f-511b-4bbd-8a31-de9c950fc7c7)
- FDA Inspection 920920 - 2015-03-20

Company: https://www.keypedia.com/companies/anshi-pharmaceutical-zhongshan-inc/233f6e41-0b8b-469b-8394-d9e9f3486774

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c